Biotome AB
559032-1666ActiveDeveloping precision peptide technology for advanced antibody diagnostics.
Biotechnology Company / Diagnostics Developerbiotome.com.au
Yleiskatsaus
- 0
- Työntekijät
- 500–749t SEK
- Liikevaihto
- 2015
- Perustettu
Avainpäättäjät
Dr Samuel Lundin
Founder / CEO
Luke Marshall
Chief Technology Officer
Dr Barry Marshall
Co-founder / Advisor
Ajay Nair
Director
+3 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Biotome is a biotechnology company focused on revolutionizing antibody diagnostics using next-generation peptide technology. They address the limitations of traditional serology tests by providing a precision immunology platform that delivers stronger signals and eliminates background noise. The com...
Glykos Holding Oy